Veracyte (VCYT) Market Capitalization (2013 - 2026)

Veracyte has disclosed Market Capitalization across 14 years of filings, most recently posting $4.7 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 122.16% year-over-year to $4.7 billion; the TTM figure through Jun 2026 stood at $4.7 billion (up 122.16% YoY), while the FY2025 annual figure was $3.3 billion, up 8.48% from the prior year.
• Market Capitalization came in at $4.7 billion for Q2 2026 at Veracyte, up from $2.6 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $4.7 billion in Q2 2026 to a low of $1.2 billion in Q3 2022.
• Average Market Capitalization over 5 years is $2.2 billion, with a median of $2.0 billion recorded in 2022.
• Year-over-year, Market Capitalization slumped 63.91% in 2022 and surged 122.16% in 2026.
• Over 5 years, Market Capitalization stood at $1.7 billion in 2022, then advanced by 18.03% to $2.0 billion in 2023, then jumped by 52.8% to $3.1 billion in 2024, then increased by 8.48% to $3.3 billion in 2025, then jumped by 41.27% to $4.7 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $4.7 billion in Q2 2026, $2.6 billion in Q1 2026, and $3.3 billion in Q4 2025.